Long term supporter of the company and SI.
Posting for first time.
I want to believe there should be a good reason for FDA to do what they did.
Could it be- That once approved for one indication, and in the hospital shelves, FDA is worried, doctors would be tempted (for good reason) to use it (off-label) for COVID-ARDS?
This could have implications for not only - Use without full evidence, supply constraints for the indication approved, manufacturing capacity not ready, etc.
So this could be a way to buy time, while they get more evidence for COVID use, which is probably their number 1 worry at the moment.
If it is, I am still positive.
Just delays my personal plans a little bit.
Not that I was in a rush to sell.
- Forums
- ASX - By Stock
- MSB
- Ann: Update on BLA for Graft Versus Host Disease
Ann: Update on BLA for Graft Versus Host Disease, page-243
-
-
- There are more pages in this discussion • 313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.01 |
Change
-0.018(1.71%) |
Mkt cap ! $1.164B |
Open | High | Low | Value | Volume |
$1.03 | $1.04 | $1.01 | $2.206M | 2.150M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 245440 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 144022 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 242598 | 1.005 |
39 | 562463 | 1.000 |
21 | 231849 | 0.995 |
20 | 800023 | 0.990 |
10 | 89170 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 146023 | 15 |
1.015 | 91941 | 21 |
1.020 | 103859 | 18 |
1.025 | 47612 | 9 |
1.030 | 52075 | 9 |
Last trade - 11.21am 24/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online